Glaxosmithkline Consumer-healthcare

Showing 1 of 6 from 6 results
Glaxosmithkline Consumer-healthcare - Total results - 6
HUL acquires Horlicks for Rs 3,045 cr; announces completion of GSK Consumer Healthcare merger with itself
Business

HUL acquires Horlicks for Rs 3,045 cr; announces completion of GSK Consumer Healthcare merger with itself

FMCG major Hindustan Unilever on Wednesday announced the completion of GlaxoSmithKline Consumer Healthcare Ltd's merger (GSKCH) with itself

Chandigarh NCLT approves Hindustan Unilever, GlaxoSmithKline Consumer Healthcare merger deal
Business

Chandigarh NCLT approves Hindustan Unilever, GlaxoSmithKline Consumer Healthcare merger deal

FMCG major Hindustan Unilever Ltd (HUL) on Wednesday said the Chandigarh bench of National Company Law Tribunal (NCLT) has approved the scheme of amalgamation for the merger of the company and GlaxoSmithKline Consumer Healthcare (GSKCH)

GSKCH India gets CCI nod for merger deal with HUL; scheme needs to pass through various regulatory, other approvals
Business

GSKCH India gets CCI nod for merger deal with HUL; scheme needs to pass through various regulatory, other approvals

he Competition Commission of India (CCI) has approved the scheme of amalgamation between the two companies, through an-all equity deal, valuing the total business of the latter at Rs 31,700 crore.

Hindustan Unilever buys GSK's Indian Horlicks, Boost nutrition business in $3.8 billion all equity deal
Business

Hindustan Unilever buys GSK's Indian Horlicks, Boost nutrition business in $3.8 billion all equity deal

The merger of GSKCH India with HUL will be on a basis of an exchange ratio of 4.39 HUL shares for each GSKCH India Share

GSK to sell Horlicks to fund $13 bn Novartis deal; Nestle, Kraft, Unilever likely suitors, say sources
Business

GSK to sell Horlicks to fund $13 bn Novartis deal; Nestle, Kraft, Unilever likely suitors, say sources

GSK has started a strategic review of Horlicks - a malt-based drink brand popular in India – and some of its smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion on Tuesday.